2-tetradecylcyclobutanone: structure in first source
ID Source | ID |
---|---|
PubMed CID | 566940 |
CHEBI ID | 173893 |
MeSH ID | M0466229 |
Synonym |
---|
CHEBI:173893 |
35493-47-1 |
2-tetradecylcyclobutanone |
2-tetradecylcyclobutan-1-one |
cyclobutanone, 2-tetradecyl- |
HTZLOIBLMXPDGR-UHFFFAOYSA-N |
2-tetradecylcyclobutanone # |
2-(n-tetradecyl)cyclobutanone |
2-(tetradecyl)-1-cyclobutanone |
2-tetradecyl-cyclobutanone |
2-tetradecylcyclobutanone, analytical standard |
unii-6zjn11424n |
6zjn11424n , |
DTXSID10340742 |
AKOS030240094 |
cyclobutanone, 2-tetradecyl-; 2-(n-tetradecyl)cyclobutanone; 2-tetradecylcyclobutanone |
2-tcb |
Q27265783 |
SY268389 |
mfcd00801046 |
Excerpt | Relevance | Reference |
---|---|---|
" Both 2-DCB and 2-TCB in most samples were detected with good dose-response relations at all doses, while salmon was detected more than 2 kGy irradiation." | ( Analysis of 2-alkylcyclobutanones with accelerated solvent extraction to detect irradiated meat and fish. Furuta, M; Obana, H; Tanaka, Y, 2005) | 0.33 |
" To the best of our knowledge, this is the first report of 2-ACB determination by LC-MS/MS and the first analytical method allowing confident identification of irradiated food at dosage of down to 10 Gy." | ( Liquid chromatography-electrospray ionization tandem mass spectrometric analysis of 2-alkylcyclobutanones in irradiated chicken by precolumn derivatization with hydroxylamine. Chan, W; Horvatovich, P; Liu, H; Ye, Y, 2013) | 0.39 |
Class | Description |
---|---|
cyclic ketone | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.40) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |